Cargando…

Effects of Pharmacist Intervention on Community Control of Hypertension: A Randomized Controlled Trial in Zunyi, China

OBJECTIVE: We aimed to test the effects of pharmacist intervention on the community control of hypertension through a comparative randomized controlled trial. METHODS: We recruited adult hypertensive patients with comorbidity or confusion with medication (n=636) from 2 community health centers in Zu...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ying, Liu, Guoqin, Liu, Chaojie, Wang, Xianhong, Chu, Yalin, Li, Xiaoqin, Yang, Wenhao, Shen, Yewei, Wu, Fang, Zhang, Wenzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Global Health: Science and Practice 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691874/
https://www.ncbi.nlm.nih.gov/pubmed/34933984
http://dx.doi.org/10.9745/GHSP-D-20-00505
_version_ 1784618838333063168
author Li, Ying
Liu, Guoqin
Liu, Chaojie
Wang, Xianhong
Chu, Yalin
Li, Xiaoqin
Yang, Wenhao
Shen, Yewei
Wu, Fang
Zhang, Wenzhi
author_facet Li, Ying
Liu, Guoqin
Liu, Chaojie
Wang, Xianhong
Chu, Yalin
Li, Xiaoqin
Yang, Wenhao
Shen, Yewei
Wu, Fang
Zhang, Wenzhi
author_sort Li, Ying
collection PubMed
description OBJECTIVE: We aimed to test the effects of pharmacist intervention on the community control of hypertension through a comparative randomized controlled trial. METHODS: We recruited adult hypertensive patients with comorbidity or confusion with medication (n=636) from 2 community health centers in Zunyi, China. They were randomly and equally divided into 2 groups. Both groups received the usual care and participated in the community systematic management program of hypertension. Participants in the intervention group were given interventions from pharmacists, including a monthly review of medications, patient education, and medication adjustment advice to medical doctors over 6 months. Participants' blood pressure was assessed at baseline, 3 months, and 6 months. Participants' knowledge and medication adherence were measured using a questionnaire before and after the trial. RESULTS: Compared to the control group (n=298), a significantly higher percentage of participants in the intervention group (n=290) had their blood pressure under control 3 months (46.9% vs. 38.3%, P=.034) and 6 months (60.7% vs. 40.9%, P<.001) after the interventions. Difference-in-differences analyses showed that the pharmacist intervention resulted in an increase in knowledge scores by 12.55 points (P<.001), a decrease in systolic blood pressure by 6.65 mmHg (P=.001), and a decrease in diastolic blood pressure by 7.26 mmHg (P<.001) compared to the controls after adjustment for variations in potential confounding factors. The odds of participants passing the hypertension knowledge tests in the intervention group was 4.45 times those in the control group (P<.001). Similarly, it was found that the intervention group had higher odds of not needing any medication adjustments (adjusted odds ratio [AOR]=2.75, P<.001) and having their blood pressure under control (AOR=2.18, P=.002) compared to the control group. CONCLUSION: It is evident that pharmacist intervention has significant short-term effects on improving the knowledge and medication adherence of hypertensive patients, as well as timely medication adjustments from medical doctors, resulting in lowered blood pressure and an increased control rate. Further studies should explore the long-term sustainability of the effects of community pharmacist intervention.
format Online
Article
Text
id pubmed-8691874
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Global Health: Science and Practice
record_format MEDLINE/PubMed
spelling pubmed-86918742021-12-31 Effects of Pharmacist Intervention on Community Control of Hypertension: A Randomized Controlled Trial in Zunyi, China Li, Ying Liu, Guoqin Liu, Chaojie Wang, Xianhong Chu, Yalin Li, Xiaoqin Yang, Wenhao Shen, Yewei Wu, Fang Zhang, Wenzhi Glob Health Sci Pract Original Article OBJECTIVE: We aimed to test the effects of pharmacist intervention on the community control of hypertension through a comparative randomized controlled trial. METHODS: We recruited adult hypertensive patients with comorbidity or confusion with medication (n=636) from 2 community health centers in Zunyi, China. They were randomly and equally divided into 2 groups. Both groups received the usual care and participated in the community systematic management program of hypertension. Participants in the intervention group were given interventions from pharmacists, including a monthly review of medications, patient education, and medication adjustment advice to medical doctors over 6 months. Participants' blood pressure was assessed at baseline, 3 months, and 6 months. Participants' knowledge and medication adherence were measured using a questionnaire before and after the trial. RESULTS: Compared to the control group (n=298), a significantly higher percentage of participants in the intervention group (n=290) had their blood pressure under control 3 months (46.9% vs. 38.3%, P=.034) and 6 months (60.7% vs. 40.9%, P<.001) after the interventions. Difference-in-differences analyses showed that the pharmacist intervention resulted in an increase in knowledge scores by 12.55 points (P<.001), a decrease in systolic blood pressure by 6.65 mmHg (P=.001), and a decrease in diastolic blood pressure by 7.26 mmHg (P<.001) compared to the controls after adjustment for variations in potential confounding factors. The odds of participants passing the hypertension knowledge tests in the intervention group was 4.45 times those in the control group (P<.001). Similarly, it was found that the intervention group had higher odds of not needing any medication adjustments (adjusted odds ratio [AOR]=2.75, P<.001) and having their blood pressure under control (AOR=2.18, P=.002) compared to the control group. CONCLUSION: It is evident that pharmacist intervention has significant short-term effects on improving the knowledge and medication adherence of hypertensive patients, as well as timely medication adjustments from medical doctors, resulting in lowered blood pressure and an increased control rate. Further studies should explore the long-term sustainability of the effects of community pharmacist intervention. Global Health: Science and Practice 2021-12-31 /pmc/articles/PMC8691874/ /pubmed/34933984 http://dx.doi.org/10.9745/GHSP-D-20-00505 Text en © Li et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited. To view a copy of the license, visit https://creativecommons.org/licenses/by/4.0/. When linking to this article, please use the following permanent link: https://doi.org/10.9745/GHSP-D-20-00505
spellingShingle Original Article
Li, Ying
Liu, Guoqin
Liu, Chaojie
Wang, Xianhong
Chu, Yalin
Li, Xiaoqin
Yang, Wenhao
Shen, Yewei
Wu, Fang
Zhang, Wenzhi
Effects of Pharmacist Intervention on Community Control of Hypertension: A Randomized Controlled Trial in Zunyi, China
title Effects of Pharmacist Intervention on Community Control of Hypertension: A Randomized Controlled Trial in Zunyi, China
title_full Effects of Pharmacist Intervention on Community Control of Hypertension: A Randomized Controlled Trial in Zunyi, China
title_fullStr Effects of Pharmacist Intervention on Community Control of Hypertension: A Randomized Controlled Trial in Zunyi, China
title_full_unstemmed Effects of Pharmacist Intervention on Community Control of Hypertension: A Randomized Controlled Trial in Zunyi, China
title_short Effects of Pharmacist Intervention on Community Control of Hypertension: A Randomized Controlled Trial in Zunyi, China
title_sort effects of pharmacist intervention on community control of hypertension: a randomized controlled trial in zunyi, china
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8691874/
https://www.ncbi.nlm.nih.gov/pubmed/34933984
http://dx.doi.org/10.9745/GHSP-D-20-00505
work_keys_str_mv AT liying effectsofpharmacistinterventiononcommunitycontrolofhypertensionarandomizedcontrolledtrialinzunyichina
AT liuguoqin effectsofpharmacistinterventiononcommunitycontrolofhypertensionarandomizedcontrolledtrialinzunyichina
AT liuchaojie effectsofpharmacistinterventiononcommunitycontrolofhypertensionarandomizedcontrolledtrialinzunyichina
AT wangxianhong effectsofpharmacistinterventiononcommunitycontrolofhypertensionarandomizedcontrolledtrialinzunyichina
AT chuyalin effectsofpharmacistinterventiononcommunitycontrolofhypertensionarandomizedcontrolledtrialinzunyichina
AT lixiaoqin effectsofpharmacistinterventiononcommunitycontrolofhypertensionarandomizedcontrolledtrialinzunyichina
AT yangwenhao effectsofpharmacistinterventiononcommunitycontrolofhypertensionarandomizedcontrolledtrialinzunyichina
AT shenyewei effectsofpharmacistinterventiononcommunitycontrolofhypertensionarandomizedcontrolledtrialinzunyichina
AT wufang effectsofpharmacistinterventiononcommunitycontrolofhypertensionarandomizedcontrolledtrialinzunyichina
AT zhangwenzhi effectsofpharmacistinterventiononcommunitycontrolofhypertensionarandomizedcontrolledtrialinzunyichina